Open AccessDIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia
Author(s) -
Wei Liu,
Yaoting Sun,
Weigang Ge,
Fangfei Zhang,
Lin Gan,
Yi Zhu,
Tiannan Guo,
Kexin Liu
Publication year - 2021
Publication title -
molecular and cellular proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.757
H-Index - 187
eISSN - 1535-9484
pISSN - 1535-9476
DOI - 10.1016/j.mcpro.2021.100187
Subject(s) - myeloid leukemia , drug resistance , idh2 , isocitrate dehydrogenase , pharmacology , cancer research , imatinib mesylate , proteome , idh1 , imatinib , medicine , biology , bioinformatics , biochemistry , enzyme , mutation , gene , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom